Related references
Note: Only part of the references are listed.Functional role and regulation of permeability-glycoprotein (P-gp) in the fetal membrane during drug transportation
Ananthkumar Kammala et al.
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2022)
Central Nervous System Distribution of an Opioid Agonist Combination with Synergistic Activity
Jessica I. Griffith et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2022)
Infectious Complications of Injection Drug Use
Laura R. Marks et al.
MEDICAL CLINICS OF NORTH AMERICA (2022)
Opioid-Induced Constipation in Real-World Practice: A Physician Survey, 1 Year Later
Domenico Alvaro et al.
PAIN AND THERAPY (2022)
Expert advice for prescribing cannabis medicines for patients with epilepsy-drawn from the Australian clinical experience
John Lawson et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2022)
Pharmacologic agents directed at the treatment of pain associated with maladaptive neuronal plasticity
Joseph V. Pergolizzi et al.
EXPERT OPINION ON PHARMACOTHERAPY (2022)
Current and Future Therapeutic Options in Pain Management: Multi-mechanistic Opioids Involving Both MOR and NOP Receptor Activation
Flaminia Coluzzi et al.
CNS DRUGS (2022)
Chemical molecular-based approach to overcome multidrug resistance in cancer by targeting P-glycoprotein (P-gp)
Hang Zhang et al.
MEDICINAL RESEARCH REVIEWS (2021)
Cholesterol Asymmetrically Modulates the Conformational Ensemble of the Nucleotide-Binding Domains of P-Glycoprotein in Lipid Nanodiscs
Amanda F. Clouser et al.
BIOCHEMISTRY (2021)
ABCB1/MDR1/P-gp employs an ATP-dependent twist-and-squeeze mechanism to export hydrophobic drugs
Atsushi Kodan et al.
FEBS LETTERS (2021)
Blood-Nerve Barrier (BNB) Pathology in Diabetic Peripheral Neuropathy and In Vitro Human BNB Model
Yukio Takeshita et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Cetuximab-Modified Human Serum Albumin Nanoparticles Co-Loaded with Doxorubicin and MDR1 siRNA for the Treatment of Drug-Resistant Breast Tumors
Xin Yang et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2021)
Factors and dosage formulations affecting the solubility and bioavailability of P-glycoprotein substrate drugs
Teruo Murakami et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2021)
Advances in Oral Drug Delivery
Mohammed S. Alqahtani et al.
FRONTIERS IN PHARMACOLOGY (2021)
Antiretroviral Drug Transporters and Metabolic Enzymes in Circulating Monocytes and Monocyte-Derived Macrophages of ART-Treated People Living With HIV and HIV-Uninfected Individuals
Tozammel M. D. Hoque et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2021)
Personalizing Cancer Pain Therapy: Insights from the Rational Use of Analgesics (RUA) Group
Giustino Varrassi et al.
PAIN AND THERAPY (2021)
Lipid nanocarrier of selegiline augmented anti-Parkinson's effect via P-gp modulation using quercetin
Zufika Qamar et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2021)
MRP1-targeted near infrared photoimmunotherapy for drug resistant small cell lung cancer
Fang Li et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2021)
Common Clinical Practice for Opioid-Induced Constipation: A Physician Survey
Flaminia Coluzzi et al.
JOURNAL OF PAIN RESEARCH (2021)
Factors Influencing Pain Expression in Patients with Cancer: An Expert Opinion
Sebastiano Mercadante et al.
PAIN AND THERAPY (2021)
Neural Plasticity in the Brain during Neuropathic Pain
Myeong Seong Bak et al.
BIOMEDICINES (2021)
Changes in blood-spinal cord barrier permeability and neuroimmune interactions in the underlying mechanisms of chronic pain
Karli Montague-Cardoso et al.
PAIN REPORTS (2021)
Gene/paclitaxel co-delivering nanocarriers prepared by framework-induced self-assembly for the inhibition of highly drug-resistant tumors
Chenglong Wang et al.
ACTA BIOMATERIALIA (2020)
Probing cholesterol binding and translocation in P-glycoprotein
Sundar Thangapandian et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2020)
Effect of P-glycoprotein (P-gp) Inducers on Exposure of P-gp Substrates: Review of Clinical Drug-Drug Interaction Studies
Mohamed Elmeliegy et al.
CLINICAL PHARMACOKINETICS (2020)
Tapentadol prolonged release for managing moderate to severe chronic neck pain with or without a neuropathic component
Flaminia Coluzzi et al.
CURRENT MEDICAL RESEARCH AND OPINION (2020)
Medicinal chemistry strategies to discover P-glycoprotein inhibitors: An update
Jinyun Dong et al.
DRUG RESISTANCE UPDATES (2020)
Modulation of expression/function of intestinal P-glycoprotein under disease states
Teruo Murakami et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2020)
P-glycoprotein: a role in the export of amyloid-β in Alzheimer's disease?
Amanda B. Chai et al.
FEBS JOURNAL (2020)
Expression and Cellular Distribution of P-Glycoprotein and Breast Cancer Resistance Protein in Amyotrophic Lateral Sclerosis Patients
Erwin A. van Vliet et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2020)
Building and Testing PPARγ Therapeutic ELB00824 with an Improved Therapeutic Window for Neuropathic Pain
Karin N. Westlund et al.
MOLECULES (2020)
Clinical Drug-Drug Interaction Studies to Evaluate the Effects of a P-Glycoprotein Inhibitor, CYP3A Inhibitors, and a CYP3A Inducer on the Pharmacokinetics of Naldemedine in Healthy Subjects
Kazuya Fukumura et al.
CLINICAL DRUG INVESTIGATION (2020)
P-Glycoprotein Inhibition Exacerbates Paclitaxel Neurotoxicity in Neurons and Patients With Cancer
Tore B. Stage et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
Peripheral Opioid Receptor Antagonists for Opioid-Induced Constipation: A Primer on Pharmacokinetic Variabilities with a Focus on Drug Interactions
Jeffrey Gudin et al.
JOURNAL OF PAIN RESEARCH (2020)
Cannabidiol (CBD) Inhibited Rhodamine-123 Efflux in Cultured Vascular Endothelial Cells and Astrocytes Under Hypoxic Conditions
Jeronimo Auzmendi et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2020)
PD-L1 monoclonal antibody-decorated nanoliposomes loaded with Paclitaxel and P-gp transport inhibitor for the synergistic chemotherapy against multidrug resistant gastric cancers
Jinling Yu et al.
NANOSCALE RESEARCH LETTERS (2020)
The Effect of Opiates on Bone Formation and Bone Healing
Flaminia Coluzzi et al.
CURRENT OSTEOPOROSIS REPORTS (2020)
C-X-C Motif Chemokine 10 Contributes to the Development of Neuropathic Pain by Increasing the Permeability of the Blood-Spinal Cord Barrier
Hao-Ling Li et al.
FRONTIERS IN IMMUNOLOGY (2020)
Naldemedine: A New Option for OIBD
Flaminia Coluzzi et al.
JOURNAL OF PAIN RESEARCH (2020)
Developments in combined analgesic regimens for improved safety in postoperative pain management
Joseph V. Pergolizzi et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2020)
A novel approach of targeting refractory epilepsy: Need of an hour
Nitika Garg et al.
BRAIN RESEARCH BULLETIN (2020)
Safe Use of Opioids in Chronic Kidney Disease and Hemodialysis Patients: Tips and Tricks for Non-Pain Specialists
Flaminia Coluzzi et al.
THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2020)
Dual Inhibitors as a New Challenge for Cancer Multidrug Resistance Treatment
Tijana Stankovic et al.
CURRENT MEDICINAL CHEMISTRY (2019)
Exploring movement and energy in human P-glycoprotein conformational rearrangement
Yue Zhang et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2019)
Evidence for the Interaction of A3 Adenosine Receptor Agonists at the Drug-Binding Site(s) of Human P-glycoprotein (ABCB1)
Biebele Abel et al.
MOLECULAR PHARMACOLOGY (2019)
Mitochondria P-glycoprotein confers paclitaxel resistance on ovarian cancer cells
Weina Guo et al.
ONCOTARGETS AND THERAPY (2019)
Tapentadol in the management of cancer pain: current evidence and future perspectives
Hans G. Kress et al.
JOURNAL OF PAIN RESEARCH (2019)
Tapentadol: an effective option for the treatment of back pain
Flaminia Coluzzi et al.
JOURNAL OF PAIN RESEARCH (2019)
Drug-drug Interactions of P-gp Substrates Unrelated to CYP Metabolism
Yumiko Akamine et al.
CURRENT DRUG METABOLISM (2019)
Minimal contribution of P-gp on the low brain distribution of naldemedine, a peripherally acting μ-opioid receptor antagonist
Ryosuke Watari et al.
DRUG METABOLISM AND PHARMACOKINETICS (2019)
ATP-dependent thermostabilization of human P-glycoprotein (ABCB1) is blocked by modulators
Sabrina Lusvarghi et al.
BIOCHEMICAL JOURNAL (2019)
Pain Management in Patients with Multiple Myeloma: An Update
Flaminia Coluzzi et al.
CANCERS (2019)
Pain chronification: what should a non-pain medicine specialist know?
Bart Morlion et al.
CURRENT MEDICAL RESEARCH AND OPINION (2018)
Chronic morphine exposure potentiates p-glycoprotein trafficking from nuclear reservoirs in cortical rat brain microvessels
Charles P. Schaefer et al.
PLOS ONE (2018)
P-Glycoprotein on Blood-Brain Barrier Plays a Vital Role in Fentanyl Brain Exposure and Respiratory Toxicity in Rats
Chenchen Yu et al.
TOXICOLOGICAL SCIENCES (2018)
Mapping discontinuous epitopes for MRK-16, UIC2 and 4E3 antibodies to extracellular loops 1 and 4 of human P-glycoprotein
Shahrooz Vahedi et al.
SCIENTIFIC REPORTS (2018)
Oral methylnaltrexone does not negatively impact analgesia in patients with opioid-induced constipation and chronic noncancer pain
Lynn R. Webster et al.
JOURNAL OF PAIN RESEARCH (2018)
Acute pain alters P-glycoprotein-containing protein complexes in rat cerebral microvessels: Implications for P-glycoprotein trafficking
Margaret E. Tome et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2018)
Structural and functional aspects of P-glycoprotein and its inhibitors
Shirin Mollazadeh et al.
LIFE SCIENCES (2018)
Modulation of Opioid Transport at the Blood-Brain Barrier by Altered ATP-Binding Cassette (ABC) Transporter Expression and Activity
Junzhi Yang et al.
PHARMACEUTICS (2018)
Expression of MATE1, P-gp, OCTN1 and OCTN2, in epithelial and immune cells in the lung of COPD and healthy individuals
Tove Berg et al.
RESPIRATORY RESEARCH (2018)
Region-specific disruption of the blood-brain barrier following repeated inflammatory dural stimulation in a rat model of chronic trigeminal allodynia
Nathan T. Fried et al.
CEPHALALGIA (2018)
The application of P-gp inhibiting phospholipids as novel oral bioavailability enhancers - An in vitro and in vivo comparison
Manuel Weinheimer et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
Insights Into the Molecular Mechanism of Triptan Transport by P-glycoprotein
Laura A. Wilt et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
Effect of major gastrointestinal tract surgery on the absorption and efficacy of direct acting oral anticoagulants (DOACs)
Hakeam A. Hakeam et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2017)
Effect of P-glycoprotein inhibition at the blood-brain barrier on brain distribution of (R)-[11C]verapamil in elderly vs. young subjects
Martin Bauer et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2017)
The opioid epidemic: a central role for the blood brain barrier in opioid analgesia and abuse
Charles P. Schaefer et al.
FLUIDS AND BARRIERS OF THE CNS (2017)
Clinical Evaluation of Modified Release and Immediate Release Tacrolimus Formulations
Simon Tremblay et al.
AAPS JOURNAL (2017)
Treatment for chronic low back pain: the focus should change to multimodal management that reflects the underlying pain mechanisms
Gerhard Mueller-Schwefe et al.
CURRENT MEDICAL RESEARCH AND OPINION (2017)
Paclitaxel-induced sensory peripheral neuropathy is associated with an ABCB1 single nucleotide polymorphism and older age in Japanese
Yuko Tanabe et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2017)
P-glycoprotein Function in the Rodent Brain Displays a Daily Rhythm, a Quantitative In Vivo PET Study
Heli Savolainen et al.
AAPS JOURNAL (2016)
P-glycoprotein traffics from the nucleus to the plasma membrane in rat brain endothelium during inflammatory pain
Margaret E. Tome et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2016)
Use of PET Imaging to Evaluate Transporter-Mediated Drug-Drug Interactions
Oliver Langer
JOURNAL OF CLINICAL PHARMACOLOGY (2016)
Effect of Subchronic Intravenous Morphine Infusion and Naloxone-Precipitated Morphine Withdrawal on P-gp and Bcrp at the Rat Blood-Brain Barrier
Catarina Chaves et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2016)
P-glycoprotein inhibitors improve effective dose and time of pregabalin to inhibit intermittent cold stress-induced central pain
Takehiro Mukae et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2016)
Polymorphism of CYP3A4 and ABCB1 genes increase the risk of neuropathy in breast cancer patients treated with paclitaxel and docetaxel
Tulay Kus et al.
ONCOTARGETS AND THERAPY (2016)
Relationship between ABCB1 polymorphisms and serum methadone concentration in patients undergoing methadone maintenance therapy (MMT)
Zalina Zahari et al.
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE (2016)
The role of naloxegol in the management of opioid-induced bowel dysfunction
Wojciech Leppert et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2016)
Simulation and Prediction of the Drug-Drug Interaction Potential of Naloxegol by Physiologically Based Pharmacokinetic Modeling
D. Zhou et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2016)
The mineralocorticoid receptor antagonist spironolactone enhances morphine antinociception
T. O. Lilius et al.
EUROPEAN JOURNAL OF PAIN (2014)
Blood-nerve barrier dysfunction contributes to the generation of neuropathic pain and allows targeting of injured nerves for pain relief
Tony K. Y. Lim et al.
PAIN (2014)
Impact of ABCB1 and CYP2B6 Genetic Polymorphisms on Methadone Metabolism, Dose and Treatment Response in Patients with Opioid Addiction: A Systematic Review and Meta-Analysis
Brittany B. Dennis et al.
PLOS ONE (2014)
P-glycoprotein Modulates Morphine Uptake into the CNS: A Role for the Non-steroidal Anti-inflammatory Drug Diclofenac
Lucy Sanchez-Covarrubias et al.
PLOS ONE (2014)
Impact of P-glycoprotein at the blood-brain barrier on the uptake of heroin and its main metabolites: behavioral effects and consequences on the transcriptional responses and reinforcing properties
Marianne Seleman et al.
PSYCHOPHARMACOLOGY (2014)
P-glycoprotein in the Developing Human Brain: A Review of the Effects of Ontogeny on the Safety of Opioids in Neonates
Jessica Lam et al.
THERAPEUTIC DRUG MONITORING (2014)
Coadministration of P-Glycoprotein Modulators on Loperamide Pharmacokinetics and Brain Distribution
Rita Nieto Montesinos et al.
DRUG METABOLISM AND DISPOSITION (2014)
In vivo induction of P-glycoprotein expression at the mouse blood-brain barrier: an intracerebral microdialysis study
Gary N. Y. Chan et al.
JOURNAL OF NEUROCHEMISTRY (2013)
Acetaminophen Modulates P-Glycoprotein Functional Expression at the Blood-Brain Barrier by a Constitutive Androstane Receptor-Dependent Mechanism
Lauren M. Slosky et al.
MOLECULAR PHARMACOLOGY (2013)
Respiratory toxicity of buprenorphine results from the blockage of P-glycoprotein-mediated efflux of norbuprenorphine at the blood-brain barrier in mice
Hisham Alhaddad et al.
CRITICAL CARE MEDICINE (2012)
Intracellular trafficking of P-glycoprotein
Dong Fu et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2012)
P-glycoprotein trafficking at the blood-brain barrier altered by peripheral inflammatory hyperalgesia
Gwen McCaffrey et al.
JOURNAL OF NEUROCHEMISTRY (2012)
1a,25-Dihydroxyvitamin D3-liganded vitamin D receptor increases expression and transport activity of P-glycoprotein in isolated rat brain capillaries and human and rat brain microvessel endothelial cells
Matthew R. Durk et al.
JOURNAL OF NEUROCHEMISTRY (2012)
Induction of P-glycoprotein and Bcrp at the rat blood-brain barrier following a subchronic morphine treatment is mediated through NMDA/COX-2 activation
Salah Yousif et al.
JOURNAL OF NEUROCHEMISTRY (2012)
Lack of Evidence for Involvement of P-Glycoprotein in Brain Uptake of the Centrally Acting Analgesic, Tramadol in the Rat
Behjat Sheikholeslami et al.
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES (2012)
P-Glycoprotein Is a Major Determinant of Norbuprenorphine Brain Exposure and Antinociception
Sarah M. Brown et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Opioid Transport by ATP-Binding Cassette Transporters at the Blood-Brain Barrier: Implications for Neuropsychopharmacology
Nicolas Tournier et al.
CURRENT PHARMACEUTICAL DESIGN (2011)
Opioid Analgesics and P-Glycoprotein Efflux Transporters: A Potential Systems-Level Contribution to Analgesic Tolerance
Susan L. Mercer et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2011)
Regulation of P-glycoprotein by orphan nuclear receptors in human brain microvessel endothelial cells
Gary N. Y. Chan et al.
JOURNAL OF NEUROCHEMISTRY (2011)
Efflux transporters- and cytochrome P-450-mediated interactions between drugs of abuse and antiretrovirals
Dhananjay Pal et al.
LIFE SCIENCES (2011)
Regulation of BCRP (ABCG2) and P-Glycoprotein (ABCB1) by Cytokines in a Model of the Human Blood-Brain Barrier
Birk Poller et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2010)
Tapentadol and its two mechanisms of action: Is there a new pharmacological class of centrally-acting analgesics on the horizon?
Hans G. Kress
EUROPEAN JOURNAL OF PAIN (2010)
The influence of ATP-binding cassette sub-family B member-1 (ABCB1) genetic polymorphisms on acute and chronic pain after intrathecal morphine for caesarean section: a prospective cohort study
A. T. Sia et al.
INTERNATIONAL JOURNAL OF OBSTETRIC ANESTHESIA (2010)
Blood-Brain Barrier Transport of Naloxone Does Not Involve P-glycoprotein-Mediated Efflux
Toyofumi Suzuki et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2010)
Pharmacological Properties of MK-3207, a Potent and Orally Active Calcitonin Gene-Related Peptide Receptor Antagonist
Christopher A. Salvatore et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Uptake/Efflux Transport of Tramadol Enantiomers and O-Desmethyl-Tramadol: Focus on P-Glycoprotein
Mouna Kanaan et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2009)
P-glycoprotein is not involved in the differential oral potency of naloxone and naltrexone
Mouna Kanaan et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2009)
Dexamethasone increases expression and activity of multidrug resistance transporters at the rat blood-brain barrier
Vishal S. Narang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2008)
Nociceptive inhibition prevents inflammatory pain induced changes in the blood-brain barrier
Christopher R. Campos et al.
BRAIN RESEARCH (2008)
Mechanism of ritonavir changes in methadone pharmacokinetics and pharmacodynamics: II. Ritonavir effects on CYP3A and P-glycoprotein activities
E. D. Kharasch et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
ABCB1 (MDR1) genetic variants are associated with methadone doses required for effective treatment of heroin dependence
Orna Levran et al.
HUMAN MOLECULAR GENETICS (2008)
Opioids and efflux transporters. Part 2: P-glycoprotein substrate activity of 3- and 6-substituted morphine analogs
Christopher W. Cunningham et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Association of ABCB1/MDR1 and OPRM1 gene polymorphisms with morphine pain relief
D. Campa et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Negative relationship between morphine analgesia and P-glycoprotein expression levels in the brain
Wakako Hamabe et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2007)
Oxycodone induces overexpression of p-glycoprotein (ABCB1) and affects paclitaxel's tissue distribution in Sprague Dawley rats
Hazem E. Hassan et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2007)
P-Glycoprotein is not present in mitochondrial membranes
Jill K. Paterson et al.
EXPERIMENTAL CELL RESEARCH (2007)
Modulation of p-glycoprotein function by caveolin-1 phosphorylation
Stephane Barakat et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Tumor necrosis factor α and endothelin-1 increase P-glycoprotein expression and transport activity at the blood-brain barrier
Bjorn Bauer et al.
MOLECULAR PHARMACOLOGY (2007)
Pharmacokinetics and pharmacodynamics of alfentanil in P-glycoprotein-competent and P-glycoprotein-deficient mice: P-glycoprotein efflux alters alfentanil brain disposition and antinociception
J. Cory Kalvass et al.
DRUG METABOLISM AND DISPOSITION (2007)
P-glycoprotein mediates brain-to-blood efflux transport of buprenorphine across the blood-brain barrier
Toyofumi Suzuki et al.
JOURNAL OF DRUG TARGETING (2007)
In vivo activation of human pregnane X receptor tightens the blood-brain barrier to methadone through P-glycoprotein up-regulation
Bjorn Bauer et al.
MOLECULAR PHARMACOLOGY (2006)
Modulation of P-glycoprotein activity by cannabinoid molecules in HK-2 renal cells
P Nieri et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Therapeutic benefit of eletriptan compared to sumatriptan for the acute relief of migraine pain - results of a model-based meta-analysis that accounts for encapsulation
JW Mandema et al.
CEPHALALGIA (2005)
The 40-mg dose of eletriptan: comparative efficacy and tolerability versus sumatriptan 100 mg
HC Diener et al.
EUROPEAN JOURNAL OF NEUROLOGY (2004)
The brain entry of risperidone and 9-hydroxyrisperidone is greatly limited by P-glycoprotein
JS Wang et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2004)
Involvement of P-glycoprotein in blood-brain barrier transport of pentazocine in rats using brain uptake index method
Y Moriki et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2004)
Eletriptan for the treatment of migraine in patients with previous poor response or tolerance to oral sumatriptan
M Färkkilä et al.
CEPHALALGIA (2003)
Eletriptan vs sumatriptan -: A double-blind, placebo-controlled, multiple migraine attack study
G Sandrini et al.
NEUROLOGY (2002)
Interaction of morphine, fentanyl, sufentanil, affientanil, and loperamide with the efflux drug transporter p-glycoprotein
C Wandel et al.
ANESTHESIOLOGY (2002)
Decreased cortisol secretion by adrenal glands perfused with the P-glycoprotein inhibitor valspodar and mitotane or doxorubicin
T Cufer et al.
ANTI-CANCER DRUGS (2000)
Eletriptan in acute migraine: A double-blind, placebo-controlled comparison to sumatriptan
PJ Goadsby et al.
NEUROLOGY (2000)
Share Paper
